NovaLipids management team is committed to building a leading biotechnology company that that meets the diverse vaccine and drug delivery needs of the health industry. With broad backgrounds in science, industry and academia, the Company’s management team possesses the necessary prerequisites to ensure rapid corporate growth and successful implementation of commercialization strategies.

President

Dr. Kevin Keough currently holds the position of Chief Scientist with Health Canada. In this position, Dr. Keoughs’ mandate involves bringing leadership, coherence and expertise to the overall strategic direction of Health Canada. Prior being seconded to Health Canada, Dr. Keough was Vice-President (Research and International Relations) of Memorial University of Newfoundland. Dr. Keoughs’ current research interests include the molecular organization and function in lung surfactant and membranes and liposomes as carriers for vaccines and drugs.

Dr. Keough is the Deputy Chair of the Council of Science and Technology Advisors, an expert advisory panel that provides guidance on federal science and technology issues. As a former executive member of the Medical Research Council, Dr. Keough played a lead role in the creation of the Canadian Institutes for Health Research. He is a founding member of the Board of Directors of Genome Canada. Dr. Keough is also a member of the Boards of Directors of the Genesis Group Inc., the Canadian Centre of Fisheries Innovation, the Canadian Centre for Marine Communications, the Newfoundland and Labrador Science Centre, and AquaNet, the Network of Centres of Excellence in aquaculture. He is a Past-President of the Canadian Federation of Biological Societies, the Canadian Society of Biochemistry and Molecular Biology and the Canadian Association of University Research Administrators.

Director - Board

Mr. David J. King holds the position of President and CEO of the Genesis Group Incorporated, the technology transfer arm of Memorial University. Prior to joining Genesis, Mr. King spent several years with the federal government involved in regional economic development in Atlantic Canada. Mr. King has a varied background in such diverse areas as manufacturing, mining and research and for the past 20 years he has been involved in the commercialization of technology.